Liccardi G, Senna G, Russo M, Bonadonna P, Crivellaro M, Dama A, D'Amato M, D'Amato G, Canonica G W, Passalacqua G
Dept of Chest Diseases, Division of Pneumology and Allergology "A. Cardarelli" Hospital, Naples.
J Investig Allergol Clin Immunol. 2004;14(2):104-7.
The nocebo effect is the onset of untoward reactions following the administration of an indifferent substance. The oral challenge with alternative drugs plays a central role in the management of drug allergy and the use of inert substances is part of this procedure. We evaluated the occurrence and clinical characteristics of nocebo effect in patients with adverse drug reactions. Six hundred patients, seen in three different centres (Genoa, Naples and Verona) with a history of reactions to drugs, underwent a blind oral challenge with the administration of an indifferent substance and active drugs. The administration of an inert substance provoked untoward reactions in 54 patients (27%) in Verona, 60 (30%) in Naples and 48 (24%) in Genoa. The overall occurrence of nocebo effect was 27%. The majority of reactions were subjective symptoms (itching, malaise, headache etc), perceived as troublesome by all subjects. The occurrence was significantly higher in women than in men. Our data, collected in a large population, confirm that the nocebo effect occurs frequently in clinical practice. In managing adverse drug reactions through oral challenge the nocebo effect is mandatory to recognize false positive responses.
反安慰剂效应是指给予无活性物质后出现不良反 应。使用替代药物进行口服激发试验在药物过敏的管理中起着核心作用,而使用惰性物质是该过程的一部分。我们评估了药物不良反应患者中反安慰剂效应的发生率及临床特征。600名有药物反应史的患者在三个不同中心(热那亚、那不勒斯和维罗纳)接受了无活性物质和活性药物的盲法口服激发试验。在维罗纳,给予惰性物质后有54名患者(27%)出现不良反应,在那不勒斯为60名(30%),在热那亚为48名(24%)。反安慰剂效应的总体发生率为27%。大多数反应为主观症状(瘙痒、不适、头痛等),所有受试者均认为这些症状令人烦恼。女性的发生率显著高于男性。我们在大量人群中收集的数据证实,反安慰剂效应在临床实践中经常发生。在通过口服激发试验管理药物不良反应时,必须认识到反安慰剂效应以识别假阳性反应。